OR WAIT null SECS
© 2023 MJH Life Sciences and Consultant Live. All rights reserved.
February 17, 2023
A systematic review and meta-analysis of data from more than a dozen RCTs provide a comprehensive overview of the effects of metformin plus oral contraceptives compared to oral contraceptives alone in women with polycystic ovary syndrome without obesity.
October 11, 2022
A look at data from 1600 women with PCOS from Alabama and California provides new insight into regional differences in presentation of the disease, including an increased risk of excess hair and insulin resistance.
July 14, 2022
New research suggests being born to a mother with polycystic ovary syndrome was associated with a 32% increase in risk of childhood hospitalizations among offspring.
June 22, 2022
Data from a Johns Hopkins Medicine-led analysis provide insight into the risk of cardiovascular complications among women with polycystic ovary syndrome during delivery hospitalizations compared to their counterparts without PCOS.
May 24, 2022
Data presented at the European Congress of Endocrinology detail genetic and observational associations between obesity, and markers of body composition on the likelihood of developing PCOS later in life.
February 15, 2022
A systematic review and meta-analysis suggest approximately 20% of girls with type 2 diabetes also had polycystic ovary syndrome.
February 01, 2022
Results of a recent study shed light on observational and genetic associations between obesity and multiple female reproductive disorders, including uterine fibroids, PCOS, and heavy menstrual bleeding.
October 15, 2021
A pair of studies provide insight into the increased risk of dysglycemia among women with PCOS and the potential influence of combined oral contraceptive pills on this risk in a population-based cohort.
September 22, 2021
A meta-analysis builds upon previous research and provides new insight into the total costs of diagnosis and treating PCOS as well as the costs of treating PCOS-related comorbidities.
September 14, 2021
An overlooked aspect of an under-discussed condition, Andrea Dunaif, MD, provided an overview of the cardiovascular risk seen among women with polycystic ovary syndrome.